Impact of Aorto-Iliac Occlusive Disease Treatment on Blood Pressure
Recruiting
N/A
Interventional Study
Aorto Iliac Occlusive Disease
Blood Pressure
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 20 (estimated)
- Sponsor
- Rijnstate Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Hypertension is a major risk factor for a variety of cardiovascular diseases. When hypertension results from increased vascular resistance due to a narrowing of the descending aorta, it can be effectively treated with stenting. More recently, evidence suggest that stenting in more distal parts of the arterial vascular bed is also associated with a reduction in blood pressure. The investigators hyp…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥18 years
* Singed informed consent
* Chronic occlusion in the infrarenal aorta and/or one or both common iliac arteries
* Total lesion length of ≥30mm
* Clinical indication for treatment of the pathology (Chronic limb threatening ischemia or disabling intermittent claudic…
Contacts